Amesite Inc. (AMST) - 10-Q Filing Summary
Business Context and Reporting Period
This Quarterly Report on Form 10-Q covers the period ended March 31, 2025. Amesite Inc. is a technology company developing AI-driven B2B and B2C solutions, including a higher education platform and the NurseMagic™ healthcare app. The company is classified as a non-accelerated filer, a smaller reporting company, and an emerging growth company. As of May 15, 2025, there were 4,572,713 shares of common stock outstanding.
Key Financial Metrics
| Metric | Three Months Ended Mar 31, 2025 | Nine Months Ended Mar 31, 2025 | Nine Months Ended Mar 31, 2024 |
|---|---|---|---|
| Net Revenue | $30,690 | $54,700 | $139,037 |
| Net Loss | $(663,418) | $(2,693,100) | $(3,222,216) |
| Loss Per Share (Basic/Diluted) | $(0.16) | $(0.85) | $(1.27) |
| Cash and Cash Equivalents | $2,858,963 (as of Mar 31, 2025) | N/A | |
| Restricted Cash | $100,000 | N/A | |
| Total Stockholders' Equity | $3,598,262 | N/A | |
| Accumulated Deficit | $(40,526,601) | N/A |
Cash Flow (Nine Months Ended Mar 31, 2025):
- Net cash used in operating activities: $(2,015,804)
- Net cash used in investing activities: $(292,199)
- Net cash provided by financing activities: $3,095,950 (primarily from a public offering)
Material Changes vs. Prior Period
- Revenue Decline: Revenue for the nine months ended March 31, 2025, decreased by approximately 60% compared to the prior year ($54,700 vs. $139,037). Management attributes this to a strategic pivot toward a larger client base with smaller, lower-risk deals, moving away from larger, cash-upfront deals that faced administrative barriers.
- Expense Reduction: Total operating expenses decreased significantly. General and administrative expenses dropped from $2,016,930 to $1,866,239 (nine months), and technology and content development expenses fell from $888,503 to $523,623. These reductions were driven by lower stock-based compensation and reduced headcount.
- Net Loss Improvement: Despite lower revenue, the net loss for the nine months ended March 31, 2025, was approximately 16% lower than the prior year period ($2.69M vs. $3.22M) due to the aforementioned expense reductions.
- Capital Raise: In January 2025, the company completed a public offering of 1,201,667 shares at $3.00 per share, raising approximately $3.1 million in net proceeds. This transaction significantly improved liquidity and stockholders' equity.
Outlook, Risks, and Contingencies
- Going Concern: The filing explicitly states there is substantial doubt about the company's ability to continue as a going concern. Management believes it may not have sufficient cash to maintain operations for the next twelve months without additional financing. Plans to raise capital are subject to market conditions and are not deemed probable.
- Nasdaq Compliance: The company received a deficiency letter in November 2024 regarding failure to meet the $2.5 million stockholders' equity requirement. Following the January 2025 offering, the company regained compliance as of January 23, 2025. However, failure to maintain compliance in future filings could result in delisting.
- Internal Controls: Management concluded that disclosure controls and procedures were not effective due to material weaknesses. Specific issues include a lack of controls for reviewing journal entries, calculating stock compensation, and recording deferred revenue. Remediation efforts are underway.
- Customer Concentration: For the nine months ended March 31, 2025, one customer represented 62% of total revenue.
Investor Verification Checklist
- Going Concern Status: Verify the company's ability to secure additional funding to sustain operations beyond the next 12 months, given the explicit substantial doubt disclosure.
- Nasdaq Listing: Monitor future filings to ensure continued compliance with Nasdaq stockholders' equity requirements to avoid delisting risks.
- Revenue Sustainability: Assess the viability of the new revenue model (smaller deals, larger client base) and the impact of high customer concentration (62% from one client).
- Internal Control Remediation: Review progress on fixing material weaknesses in financial reporting, specifically regarding stock compensation and journal entry approvals.
- Cash Burn Rate: Analyze the trajectory of operating cash burn ($2.0M used in nine months) against current cash reserves ($2.86M) to estimate runway.